Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer

X Kong, Y Qi, X Wang, R Jiang, J Wang, Y Fang… - Progress in Materials …, 2023 - Elsevier
The therapeutic effect of highly malignant triple negative breast cancer (TNBC) is negatively
affected by the formation of tumor cell resistant clone and the severe toxicity of …

[HTML][HTML] Recent advances in drug delivery systems for targeting cancer stem cells

H Duan, Y Liu, Z Gao, W Huang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Cancer stem cells (CSCs) are a subpopulation of cancer cells with functions similar to those
of normal stem cells. Although few in number, they are capable of self-renewal, unlimited …

Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges

Z Mirza, S Karim - Seminars in cancer biology, 2021 - Elsevier
Breast cancer (BC) is amongst the most lethal cancer among females and conventional
treatment methods like surgery, radiotherapy and chemotherapy are not effective enough as …

Drug release and kinetic models of anticancer drug (BTZ) from a pH-responsive alginate polydopamine hydrogel: Towards cancer chemotherapy

AI Rezk, FO Obiweluozor, G Choukrani, CH Park… - International journal of …, 2019 - Elsevier
A pH-sensitive polymeric carrier was developed in this study for local delivery of anticancer
drug bortezomib (BTZ) to cancer cells. Our strategy is based on the conjugation of BTZ to …

Smart pH-responsive polyhydralazine/bortezomib nanoparticles for remodeling tumor microenvironment and enhancing chemotherapy

R Wang, X Xu, D Li, W Zhang, X Shi, H Xu, J Hong… - Biomaterials, 2022 - Elsevier
The clinical translation of nanomedicines has been impeded by the unfavorable tumor
microenvironment (TME), particularly the tortuous vasculature networks, which significantly …

Fungal proteases as emerging biocatalysts to meet the current challenges and recent developments in biomedical therapies: an updated review

M Naeem, S Manzoor, MUH Abid, MBK Tareen… - Journal of Fungi, 2022 - mdpi.com
With the increasing world population, demand for industrialization has also increased to
fulfill humans' living standards. Fungi are considered a source of essential constituents to …

Potential and applications of nanocarriers for efficient delivery of biopharmaceuticals

A Zeb, I Rana, HI Choi, CH Lee, SW Baek, CW Lim… - Pharmaceutics, 2020 - mdpi.com
During the past two decades, the clinical use of biopharmaceutical products has markedly
increased because of their obvious advantages over conventional small-molecule drug …

Polymeric nanoparticles—Tools in a drug delivery system in selected cancer therapies

M Madej, N Kurowska, B Strzalka-Mrozik - Applied Sciences, 2022 - mdpi.com
The increase in cancer cases is undoubtedly affecting the development of new therapeutic
approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size …

The ubiquitin–proteasome system in breast cancer

D Han, L Wang, S Jiang, Q Yang - Trends in molecular medicine, 2023 - cell.com
Ubiquitin–proteasome system (UPS) is a selective proteolytic system that is associated with
the expression or function of target proteins and participates in various physiological and …

Next-generation proteasome inhibitors for cancer therapy

JE Park, Z Miller, Y Jun, W Lee, KB Kim - Translational Research, 2018 - Elsevier
Over 2 decades ago, the proteasome was considered a risky or even untenable therapeutic
target. Today, proteasome inhibitors are a mainstay in the treatment of multiple myeloma …